Vincantril

This classification denotes a vasodilating agent with the molecular formula C14H13ClN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S0KXB0NKWN, chemically known as 10-chloro-1,2,3,3a,4,5-hexahydro-6h-indolo(3,2,1-de)(1,5)naphthyridin-6-one but generally known as vincantril, which bears US NIH Compound Identifier 68854. European Medicines Agency schedules Vincantril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00056MIG. The term VINCANTRIL is an International Non-Proprietary Name. VINCANTRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vincantril under HS 29399900 and SITC 54149. As of Q4 2014, VINCANTRIL remains the US FDA Preferred Term for this commodity. Vincantril bears US NLM identifiers UMLS ID C2700250 and NCI Concept Code C77081. SMILES: Clc1cc2c3c4n(c2cc1)C(=O)CCC4NCC3.